DaVita Inc. DVA | NYSE
Next Earnings: May 12, 2025
Company Overview:
10 Year Performance Metrics:
Unlock All Reports & Research Dividend Stocks like a BOSS!
DVA Earnings, Revenue, Cash & Debt, Shares Outstaning:
Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:
Ratios, Profit Margins & Return on Capital:
Projected Future Returns & Dividends for DVA
Based on past 10-year performance, here are DVA growth metrics:
Share price CAGR of +5.48%
Dividend CAGR of +0%
Using DVA CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:
| DVA (DRIP) | DVA - No DRIP | |
|---|---|---|
| Current Price | $140.44 | $140.44 |
| Start Shares | 71.20 | 71.20 |
| Start Value | $10,000 | $10,000 |
| After 10 years: | ||
| Final Share Count | 71.20 | 71.20 |
| Dividends Payment | $0.00 | $0.00 |
| Annual Dividends | $0 | $0 |
| Yield on cost | 0.00% | 0.00% |
| Share Price | $226.93 | $140.44 |
| Total Dividends | $0 | $0 |
| Final Value | $16,159 | $10,000 |
NOTE: Above numbers are our estimate based on DVA's Dividend and Price CAGR over past 10 years.
These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.
We cannot guarantee that your actual returns will meet these estimates.
Get the best Dividend Stock Research Tools:
Company Info
DaVita Inc. (DVA) had its IPO on 1995-10-31, and is trader on NYSE stock exchange.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
DVA website: https://www.davita.com
